Skip to main content
Isomer
  1. Home
  2. Automated
  3. List of product information
  4. DAIVONEX OINTMENT 50 MCG/G [SIN06587P]

DAIVONEX OINTMENT 50 MCG/G [SIN06587P]

Active ingredients: DAIVONEX OINTMENT 50 MCG/G

Last updated 26 October 2025

Product Info

DAIVONEX OINTMENT 50 MCG/G

[SIN06587P]

Product information

Active Ingredient and Strength

CALCIPOTRIOL - 50 MCG/G

Dosage Form

OINTMENT

Manufacturer and Country

LEO LABORATORIES LIMITED - IRELAND

Registration Number

SIN06587P

Licence Holder

DKSH SINGAPORE PTE. LTD.

Forensic Classification

PRESCRIPTION ONLY MEDICINES

Anatomical Therapeutic Chemical (ATC) code

D05AX02

Indications
Psoriasis vulgaris.

Dosage and administration
Adults:
Daivonex® ointment should be applied to the affected area twice daily. For some patients adequate maintenance therapy may be achieved with less frequent application. The maximum amount used by an adult in one week should not exceed 100 g (equivalent to 5 mg of calcipotriol). If using other calcipotriol containing medicinal products concomitantly, the total weekly dose of all calcipotriol containing medical products, including Daivonex® ointment, should not exceed 5 mg of calcipotriol.

Contraindications
Hypersensitivity to the active substance or to any of the excipients.
Due to the content of calcipotriol, Daivonex® ointment is contraindicated in patients with known disorders of calcium metabolism (see Special warnings and precautions for use – please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information).